WallStSmart
CASI

CASI Pharmaceuticals Inc

NASDAQ: CASI · HEALTHCARE · BIOTECHNOLOGY

$0.21
+0.00% today

Updated 2026-04-29

Market cap
$3.21M
P/E ratio
P/S ratio
0.12x
EPS (TTM)
$-3.02
Dividend yield
52W range
$0 – $3
Volume
1.0M

CASI Pharmaceuticals Inc (CASI) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20052006200720082009201020112012201320142015201620172018201920202021202220232024
Operating cash flow$-14.52M$-20.77M$-23.52M$-20.71M$-10.21M$-4.96M$-4.27M$-2.21M$-3.28M$-4.00M$-5.51M$-6.02M$-6.40M$-28.58M$-23.24M$-25.89M$-26.84M$-21.09M$-19.97M$-29.22M
Capital expenditures$248677.00$227435.00$106721.00$134065.00$2889.00$3595.00$6001.00$48392.00$42975.00$466326.00$25396.00$223233.00$934702.00$21.77M$14.02M$19.33M$15.50M$5.61M$2.24M$240000.00
Depreciation
Stock-based comp$72988.00$1.55M$1.45M$1.09M$320156.00$271616.00$609724.00$978243.00$2.04M$2.19M$1.54M$3.00M$650440.00$6.12M$7.31M$7.82M$7.77M$7.01M$7.22M$1.31M
Free cash flow$-14.77M$-21.00M$-23.63M$-20.85M$-10.22M$-4.96M$-4.28M$-2.26M$-3.32M$-4.46M$-5.54M$-6.25M$-7.34M$-50.36M$-37.26M$-45.21M$-42.34M$-26.70M$-22.21M$-29.46M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00$367000.00$998000.00$738000.00$718000.00
Share repurchases
Debt repayment
Net change in cash$7.08M$-4.46M$-5.54M$21.96M$16.40M$40.71M$-30.58M$-18.36M